Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) — Free Cash Flow Generation Index
Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) has a Free Cash Flow Generation Index of -1.24x as of December 2024. Free cash flow of CN¥-58.25 Million represents -1% of operating cash flow (CN¥47.07 Million). See Suzhou Fushilai Pharmaceutical Co. Ltd. short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Suzhou Fushilai Pharmaceutical Co. Ltd. Free Cash Flow Generation Index (2019–2024)
Historical FCF Generation Index trend for Suzhou Fushilai Pharmaceutical Co. Ltd. across 6 annual periods. Explore Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Suzhou Fushilai Pharmaceutical Co. Ltd. (2019–2024)
Year-by-year Free Cash Flow Generation Index for Suzhou Fushilai Pharmaceutical Co. Ltd.. For the full company profile including market capitalisation, see Suzhou Fushilai Pharmaceutical Co. Ltd. market cap and net worth.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.24x | CN¥-58.25 Million | CN¥47.07 Million | CN¥105.31 Million | ▼ -320.7% |
| 2023 | 0.56x | CN¥53.15 Million | CN¥94.77 Million | CN¥41.62 Million | ▼ -16.1% |
| 2022 | 0.67x | CN¥101.08 Million | CN¥151.19 Million | CN¥50.11 Million | ▲ +12.2% |
| 2021 | 0.60x | CN¥118.98 Million | CN¥199.73 Million | CN¥80.75 Million | ▼ -1.7% |
| 2020 | 0.61x | CN¥101.16 Million | CN¥166.85 Million | CN¥65.69 Million | ▲ +14.6% |
| 2019 | 0.53x | CN¥79.62 Million | CN¥150.55 Million | CN¥70.93 Million | — |